Literature DB >> 19264552

Post-exposure vaccination against Mycobacterium tuberculosis.

Marcela Henao-Tamayo1, Gopinath S Palaniswamy, Erin E Smith, Crystal A Shanley, Baolin Wang, Ian M Orme, Randall J Basaraba, Nancy M DuTeau, Diane Ordway.   

Abstract

Enhancing immunity to tuberculosis in animal models after exposure to the infection has proved difficult. In this study we used a newly described flow cytometric technique to monitor changes in cell populations accumulating in the lungs of guinea pigs challenged by low-dose aerosol infection with Mycobacterium tuberculosis and vaccinated 10 days later. On day 40 after infection the fusion protein F36 and a pool of Ag85A and ESAT6 vaccines had significant effects on the bacterial load, showed increased expression of the activation marker CD45+ on CD4+ T cells, and reduced numbers of heterophils. Lung pathology and pathology scores were marginally improved in animals given these vaccines, but lymph node pathology was not influenced. Despite early effects no changes in long-term survival were seen. These results suggest that a single post-exposure vaccination can initially slow the disease process. However, this effect is transient, but this could be of use in an multidrug resistant/extremely drug resistant outbreak situation because it could potentially slow the infection long enough to complete drug susceptibility testing and initiate effective chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264552      PMCID: PMC3134938          DOI: 10.1016/j.tube.2009.01.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  27 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 2.  The pathogenesis of tuberculosis.

Authors:  G A Rook; R Hernandez-Pando
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

Review 3.  Pathogenesis of experimental tuberculosis in animal models.

Authors:  D N McMurray; F M Collins; A M Dannenberg; D W Smith
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 4.  Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis.

Authors:  D N McMurray
Journal:  Scand J Infect Dis       Date:  2001

5.  Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice.

Authors:  C M Johnson; A M Cooper; A A Frank; C B Bonorino; L J Wysoki; I M Orme
Journal:  Tuber Lung Dis       Date:  1997

Review 6.  Eosinophils: biology and role in disease.

Authors:  A J Wardlaw; R Moqbel; A B Kay
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

7.  Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis.

Authors:  Diane J Ordway; Leonor Costa; Marta Martins; Henrique Silveira; Leonard Amaral; Maria J Arroz; Fernando A Ventura; Hazel M Dockrell
Journal:  J Infect Dis       Date:  2004-07-13       Impact factor: 5.226

8.  Subpopulations of guinea-pig T lymphocytes defined by isoforms of the leucocyte common antigen.

Authors:  I J Hart; H Schäfer; R J Scheper; G T Stevenson
Journal:  Immunology       Date:  1992-11       Impact factor: 7.397

9.  Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis.

Authors:  C E Wilcox; D Baker; C Butter; D A Willoughby; J L Turk
Journal:  Cell Immunol       Date:  1989-04-15       Impact factor: 4.868

10.  Pulmonary necrosis resulting from DNA vaccination against tuberculosis.

Authors:  Jennifer L Taylor; Oliver C Turner; Randall J Basaraba; John T Belisle; Kris Huygen; Ian M Orme
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

View more
  5 in total

1.  Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.

Authors:  Carlos R Zárate-Bladés; Rodrigo F Rodrigues; Patricia R M Souza; Wendy M Rios; Luana S Soares; Rogério S Rosada; Izaíra T Brandão; Ana Paula Masson; Elaine M Floriano; Simone G Ramos; Celio L Silva
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

2.  Immunization with Mycobacterium tuberculosis-Specific Antigens Bypasses T Cell Differentiation from Prior Bacillus Calmette-Guérin Vaccination and Improves Protection in Mice.

Authors:  Claus Aagaard; Niels Peter Hell Knudsen; Iben Sohn; Angelo A Izzo; Hongmin Kim; Emma Holsey Kristiansen; Thomas Lindenstrøm; Else Marie Agger; Michael Rasmussen; Sung Jae Shin; Ida Rosenkrands; Peter Andersen; Rasmus Mortensen
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

3.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131

Review 4.  Novel vaccination strategies against tuberculosis.

Authors:  Peter Andersen; Stefan H E Kaufmann
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

5.  Rescuing ESAT-6 Specific CD4 T Cells From Terminal Differentiation Is Critical for Long-Term Control of Murine Mtb Infection.

Authors:  Helena Strand Clemmensen; Niels Peter Hell Knudsen; Rolf Billeskov; Ida Rosenkrands; Gregers Jungersen; Claus Aagaard; Peter Andersen; Rasmus Mortensen
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.